Hinge Health, Inc.
HNGEHealthcareNASDAQHealth Information Services · Last scanned Oct 26, 2026
Scan Results
Daily timeframeHinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. The $9.00B market capitalization puts HNGE squarely in mid-cap range for its industry. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation.
Market Cap
$9.00B
Beta
—
P/E (TTM)
36.81
P/E (Fwd)
36.48
EPS (TTM)
$3.03
EPS (Fwd)
$3.06
ROE
30.4%
ROA
7.7%
Cash
$389.4M
Total Debt
$5.9M
Free CF
$299.6M
52W Change
123.6%
Annual Financials
Cash vs Debt
Where HNGE stands vs its 150-day and 200-day moving averages
As of the October 15, 2026 close, HNGE finished 49.06% above its 150-day moving average ($70.44) and 65.90% above its 200-day moving average ($63.29). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is HNGE overbought or oversold?
At the October 15, 2026 close, HNGE's RSI(14) was 80.9, in overbought territory (above 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $389.4M in cash comfortably exceeding the $5.9M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Annual free cash flow of $299.6M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 30.4% points to exceptionally high capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 7.7% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $292.7M (2023) to $587.9M (2025), reflecting a 101% increase over the period.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing HNGE.